Pricing & Access· May 22, 2026 · 12 min read
AMCP dossier evidence gaps that weaken payer review for a new specialty drug
By Ran Chen#AMCP Dossier#Formulary#Payer Review
Topic
Evidence
Clinical and economic evidence, real-world evidence, comparative effectiveness, and health economics data for payer submissions.
Pipeline· May 22, 2026 · 13 min read
Patient-reported outcome endpoint translation from trial evidence to payer evidence
By Ran Chen#Clinical Evidence#Payer Policy#AMCP Dossier